Orix Corp 6-K, filed Oct 5, 2026
Orix Corp (IX)
About this 6-K
Orix Corp filed this 6-K on October 5, 2026.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-14856
ORIX Corporation
(Translation of Registrant’s Name into English)
World Trade Center Bldg., SOUTH TOWER, 2-4-1 Hamamatsu-cho, Minato-ku,
Tokyo, JAPAN
(Address of Principal Executive Offices)
(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F ☒ Form 40-F ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ORIX Corporation | ||||
| Date: October 5, 2026 |
By |
/s/ Masataka Yamada | ||
| Masataka Yamada | ||||
| Member of the Board of Directors | ||||
| Senior Managing Executive Officer | ||||
| Chief Financial Officer and Chief Strategy Officer | ||||
| Responsible for Corporate Strategy and Management Unit ORIX Corporation | ||||
Notice regarding Share Repurchase Status
TOKYO, Japan - October 5, 2026 - ORIX Corporation announced today the status regarding its share repurchase pursuant to the provisions of its Articles of Incorporation and Article 459, Paragraph 1 of the Companies Act, which were resolved at its Board of Directors meeting held on May 11, 2026, as follows.
| 1. Class of shares repurchased |
Common shares | |
| 2. Total number of shares repurchased |
4,021,800 shares | |
| 3. Total purchase price of shares repurchased |
JPY 24,893,849,100 | |
| 4. Repurchase Period |
From September 1, 2026 to September 30, 2026 | |
| 5. Method of share repurchase |
Market purchases based on the discretionary dealing contract regarding repurchase of own shares |
(Reference)
| 1. Details of the resolution reached at the Board of Directors meeting held on May 11, 2026 | ||
| (1) Class of shares to be repurchased |
Common shares | |
| (2) Total number of shares to be repurchased |
Up to 100,000,000 shares (approx. 9.1% of the total outstanding shares (excluding treasury shares)) | |
| (3) Total purchase price of shares to be repurchased |
Up to 250 billion yen | |
| (4) Repurchase Period |
From May 22, 2026 to March 31, 2027 | |
| (5) Method of share repurchase |
Market purchases based on the discretionary dealing contract regarding repurchase of own shares | |
| 2. Cumulative number of shares repurchased based on the above resolution at the Board of Directors Meeting (as of September 30, 2026) | ||
| (1) Total number of shares repurchased |
22,073,800 shares | |
| (2) Total purchase price of shares repurchased |
JPY 138,979,581,400 | |
Contact Information:
Investor Relations Department
ORIX Corporation
Tel: +81-3-3435-3121
About ORIX Group:
ORIX Group (ORIX Corporation TSE: 8591; NYSE: IX) was established in 1964 and has grown from its roots in leasing in Japan to become a global, diverse, and unique corporate group. Today, it is active around the world in financing and investment, life insurance, banking, asset management, real estate, concession, environment and energy, automobile-related services, industrial/ICT equipment, ships and aircraft. Since expanding outside of Japan in 1971, ORIX Group has grown its business globally and now operates in around 30 countries and regions across the world with approximately 37,000 people. ORIX Group unites globally around its Purpose: “Finding Paths. Making Impact.” combining diverse expertise and innovative thinking to help our world develop in a sustainable way. For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2026)
Caution Concerning Forward-Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2025 – March 31, 2026” furnished on Form 6-K.